| 摘要 |
The invention relates to crystalline forms of 4-[3,5-bis(2-hydroxypheny1)-[1,2,4]triazol-1-yl]benzoic acid and to its amorphous form, to processes for the preparation thereof, to compositions containing the same and their uses for the manufacture of a medicament for the treatment of the human body. Normal text
|
